Purvi D. Gada, MBBS

Purvi Gada practices at Minnesota Oncology Hematology PA in Chaska, Minnesota.

Purvi Gada's NPI, 1639209224, was assigned on March 6, 2007. Purvi Gada holds Minnesota license 17508.

Purvi Gada's primary practice is Minnesota Oncology Hematology PA, at 110105 Pioneer W Trl, Chaska, MN 55318 in Carver County. The practice phone is (952) 928-2900.

Purvi Gada's primary practice is Minnesota Oncology Hematology PA in Chaska, Minnesota. Purvi Gada is also affiliated with Abbott Northwestern Hospital. The medical group on file is Minnesota Oncology. Dmand AI also links Purvi Gada to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Purvi Gada practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Purvi Gada's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Purvi Gada is licensed in Minnesota.

CMS data shows 32,047 Medicare services from Purvi Gada across 49 procedure codes in 2024, for 246 Medicare patients. Medicare paid $202,771 for them. Every service was in an office.

CMS counts 246 Medicare patients who saw Purvi Gada in 2024. The largest group is 75 to 84, with 102 patients. 65% of them have high blood pressure, and 59% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Purvi Gada's median patient age at 67, with 69% women.

In 2024, Purvi Gada wrote 851 Medicare Part D claims for 203 patients. 82% of them were for generic drugs. CMS names the drug for 632 of them, across 25 drugs with 11 or more claims each, at $1,249,456 in total drug cost. In 2023, CMS named 583 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Purvi Gada for performance year 2024, reported through an alternative payment model (APM). Purvi Gada accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Purvi Gada as offering telehealth.

Dmand AI links 2 papers to Purvi Gada in 2016. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Purvi Gada's most frequent co-authors are Satya V. Bommakanti, MD, Leonard Saltz, MD and Neil Howard Segal, MD, PhD.

CMS Open Payments shows 112 general payments to Purvi Gada from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. AstraZeneca Pharmaceuticals LP paid the most, $49,060.